Jim Hansen, MBA, CPA

Director of Finance - EMEA at Argon Medical Devices, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Medical Equipment Manufacturing
    • 300 - 400 Employee
    • Director of Finance - EMEA
      • 2011 - Present

      P&L/BUDGETING | FINANCIAL OPERATIONS MANAGEMENT | MERGERS & ACQUISITIONS | BUSINESS INTEGRATION | COST SAVINGS  Operate as a trusted business partner with the VP – Sales (GM) to drive financial operations with strong emphasis on strategic financial and operations planning, financial forecasting, P&L management, and budgeting.  Credited with standardizing financial operations through developing/refining procedures and policies, ensuring quality assurance, internal control, and the overall financial health and solvency of the organization.  Contribute to organization’s success by providing strategic input on issues affecting the organization – administer statutory and tax compliance for all 9 EMEA entities.  Oversee and manage acquisition-related financial issues, investment opportunities, special projects, technology advancement and transformations, and business continuity action planning.  Lead FX and hedging programs and exposures (balance sheet and $30M in annual sales); control multiple FX currencies within EMEA and advise on the impact of new exposures to the business.  Developed financial and operational strategy, leading efforts to preserve company assets and report accurate financial results; complied with organizational policies and enhanced systems to raise level of organizational effectiveness. Tenure highlights include –  Integral member of the team involved in procurement of a $100M EMEA entity.  Administer a $30M sales region.  Successfully integrated $30M EMEA entity into Argon Medical, including transitioning financial operations into a new financial system.  Trained new China controller on the operations and accounting for new Chinese entity.  Purchased a current distributor worth $5M in sales.  Reduced costs and inventory commitment by transferring distributors to be sourced out of a different facility.

    • United States
    • Medical Equipment Manufacturing
    • 700 & Above Employee
    • Division Controller
      • 2005 - 2011

      M&A DUE DILIGENCE | REPORTED TO VP – FINANCE | TEAM – 7 DIRECT & 13 TOTAL | WON 2008 FINANCIAL LEADERSHIP AWARD Shouldered increasingly broad authority for financial controlling of: - V. Muller - $175M Mfr./distributor/sales of surgical instruments and containers. - OnSite - $50M service company, repairing surgical instruments and managing tray instruments.  Delivered strategic growth recommendations to the leadership through fact-based, decision-making, and insightful financial analytics.  Enabled well-run fiscal operations through establishing & steering changes in organizational fiscal policies and protocols.  Cultivated a growth-oriented culture and improved systems and technology instrumental in laying foundation for growth of business and its entities.  Developed a competitive pricing strategy for the new product lines and devised focused pricing processes for all products  Credited with developing benchmarking analysis, pricing strategy, and pay-out terms of first pre-revenue acquisition by Cardinal Health. Tenure highlights include –  Exceeded established goals by $2.6M and 7% YOY growth for a new product for V. Mueller business (Impress – Instrument Management System).  Reduced TAT for product delivery by consolidating 2 German sourcing groups.  Led successful OnSite business sale to an equity investor, including transitioning all systems and financials.  Reduced product SKUs from 32K to 23K via detailed customer and profitability analysis.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Director of Finance, PreSource
      • 2000 - 2005

      FINANCIAL PLANNING & ANALYSIS | TEAM LEADERSHIP | FINANCIAL MODELING | COST SAVINGS | FINANCIAL REPORTING | FORECASTING  Led charge to manage financial operations for 8 plants, as well as evaluating manufacturing variances, OCOS, inventory and account payable – trained and developed staff in finance and operations best practices.  Oversaw general finance activities, ensured adequate levels of internal controls regarding F&A information, and provided complex accounting, financial analysis/reporting, and budgeting.  Developed strategic and long-term financial goals and regulatory compliance of reporting; guided financial decisions by establishing, monitoring, and enforcing policies and procedures.  Conducted periodic variance analysis of budgeted, forecasted, and actual financial performance, while clearly interpreting and documenting variance drivers affecting profitability.  Advised management on financial planning, budgeting, cash flow, investment priorities, and policy matters, along with implementing an appropriate system of policies, internal controls, accounting standards, and procedures. Tenure highlights include –  Improved profitability by introducing a new activity-based model for competitive costing and pricing for PreSource medical kits.  Reduced labor costs from $14.81 to $4.8 by establishing a new custom sterile plant within Cardinal Mexico facility.  Reduced manufacturing costs by approximately 3% annually and inventory costs by 25%.

    • Director, Planning
      • 1996 - 2000

       Strategically selected in the newly created position resulting from spin-off; developed and forecasted operating cash flow ($300M) and capital expenditures ($100M).  Worked closely with senior management to develop working capital targets to meet cash flow and strategic objectives, as well as the detailed balance sheet plan.  Collaborated cross-functionally with business units and treasury to ensure achievement of the forecasted monthly operating cash flow.  Strategically selected in the newly created position resulting from spin-off; developed and forecasted operating cash flow ($300M) and capital expenditures ($100M).  Worked closely with senior management to develop working capital targets to meet cash flow and strategic objectives, as well as the detailed balance sheet plan.  Collaborated cross-functionally with business units and treasury to ensure achievement of the forecasted monthly operating cash flow.

    • United States
    • 700 & Above Employee
    • Director, Finance
      • 1995 - 1996

      Led finance function for the Mid-America region (one of 8 regions within Baxter), a $350M sales and distribution organization, with over 300 people in six states. Highly matrixed position reported directly to the Region President and interacted daily with sales team, customers, and operations.  Managed training and development of regional personnel on business economics and financial levers used to improve the business’ bottom line, enhancing financial awareness.  Revised credit/collection process with centralized A/R. Created template to reduce bad debt exposure / improve cash flow, reducing DSO 20% in six months.  Analyzed and negotiated new risk-sharing agreements with customers in order to optimize the economics of the region and the customer.

Education

  • Northwestern University - Kellogg School of Management
    MBA, Finance
    1988 - 1989
  • University of Wisconsin-Madison
    BBA, Finance / Accounting
    1981 - 1985

Community

You need to have a working account to view this content. Click here to join now